Financial Assistance Programs

Xeomin Patient Co-Pay Program

The XEOMIN® Patient Co-pay Program is designed to help eligible patients with out-of-pocket treatment expenses. The program directly reimburses eligible patients for out-of-pocket costs associated with XEOMIN therapy to help:


  • Alleviate the burden of XEOMIN co-pay expenses
  • Ensure patients have continued access to XEOMIN treatment
  • For eligible patients, this program can reimburse up to $500 in out-of-pocket costs per treatment


The XEOMIN Patient Co-pay Program is open to patients who meet the following criteria:


  • Be an appropriate patient for XEOMIN treatment as determined by their physician
  • Currently have commercial health insurance that covers treatment costs for XEOMIN
  • Not be enrolled in or eligible for Medicare, Medicare Advantage, Medicaid, Managed Medicaid,
  • TRICARE (ie, CHAMPUS), or other state or federally funded insurance plans. Please Note: this does not include federal or state employees insured by commercial health plans.
  • Not be a resident of the state of Massachusetts
  • Be at least 18 years of age


Other restrictions, terms, and conditions apply. Please see the Xeomin Patient Co-pay Program Information page for complete details and to download an application. Patients who move from commercial insurance coverage to federally or state-funded programs will no longer be eligible for the Program.


Patients must enroll themselves in the XEOMIN Patient Co-pay Program and must re-enroll annually.


‡ Merz Pharmaceuticals, LLC reserves the right to modify or discontinue any and all aspects of the program at any time and without notice.

NeboWeb Content Management System Tracking